Skip to main content

Table 2 Maximum grade toxicity recorded per patient (n = 93)

From: A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma

 

Grade 1–2

Grade 3–4

 

N

%

N

%

Anemia

19

20

1

1

Neutropenia

2

2

0

 

Thrombocytopenia

12

13

0

 

Nausea

3

3

0

 

Vomiting

2

2

0

 

Anorexia

6

7

0

 

Stomatitis

20

22

2

2

Diarrhea

15

16

3

3

Fatigue

9

10

1

1

Skin

11

12

0

 

Hepatic

12

13

0

 

Hypertension

22

24

0